Sattva Neelapu, MD, University of Texas MD Anderson Cancer Center, Houston, TX, explains the latest results for the use of axicabtagene ciloleucel in older large B-cell lymphoma patients. Dr Neelapu discusses data from both ZUMA-1 (NCT02348216) and real world data from the US Lymphoma CAR-T Consortium. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.